nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—AURKA—kidney cancer	0.166	0.897	CbGaD
Doxorubicin—thyroid cancer—kidney cancer	0.0598	0.155	CtDrD
Doxorubicin—liver cancer—kidney cancer	0.0576	0.149	CtDrD
Doxorubicin—urinary bladder cancer—kidney cancer	0.0462	0.12	CtDrD
Doxorubicin—bone cancer—kidney cancer	0.0443	0.115	CtDrD
Doxorubicin—muscle cancer—kidney cancer	0.0391	0.101	CtDrD
Doxorubicin—pancreatic cancer—kidney cancer	0.0391	0.101	CtDrD
Doxorubicin—testicular cancer—kidney cancer	0.0367	0.0952	CtDrD
Doxorubicin—lung cancer—kidney cancer	0.0316	0.0819	CtDrD
Doxorubicin—sarcoma—kidney cancer	0.0312	0.0809	CtDrD
Doxorubicin—RALBP1—Sorafenib—kidney cancer	0.0292	0.113	CbGbCtD
Doxorubicin—RALBP1—Vincristine—kidney cancer	0.0284	0.11	CbGbCtD
Doxorubicin—ABCC6—Dactinomycin—kidney cancer	0.0222	0.0856	CbGbCtD
Doxorubicin—ABCB1—kidney cancer	0.019	0.103	CbGaD
Doxorubicin—ABCC6—Vinblastine—kidney cancer	0.0139	0.0536	CbGbCtD
Doxorubicin—ABCC10—Gemcitabine—kidney cancer	0.0134	0.0517	CbGbCtD
Doxorubicin—ABCC10—Paclitaxel—kidney cancer	0.0121	0.0467	CbGbCtD
Doxorubicin—ABCC10—Vincristine—kidney cancer	0.0104	0.0403	CbGbCtD
Doxorubicin—CYP1B1—Erlotinib—kidney cancer	0.00718	0.0277	CbGbCtD
Doxorubicin—CYP1B1—Paclitaxel—kidney cancer	0.00657	0.0254	CbGbCtD
Doxorubicin—ABCB11—Paclitaxel—kidney cancer	0.00657	0.0254	CbGbCtD
Doxorubicin—ABCC3—Vincristine—kidney cancer	0.00655	0.0253	CbGbCtD
Doxorubicin—ABCC1—Dactinomycin—kidney cancer	0.00653	0.0252	CbGbCtD
Doxorubicin—ABCB11—Vinblastine—kidney cancer	0.00576	0.0223	CbGbCtD
Doxorubicin—ABCB11—Vincristine—kidney cancer	0.00566	0.0219	CbGbCtD
Doxorubicin—ABCG2—Pazopanib—kidney cancer	0.00478	0.0185	CbGbCtD
Doxorubicin—ABCC1—Paclitaxel—kidney cancer	0.00467	0.018	CbGbCtD
Doxorubicin—ABCG2—Dactinomycin—kidney cancer	0.00437	0.0169	CbGbCtD
Doxorubicin—ABCC1—Vinblastine—kidney cancer	0.00409	0.0158	CbGbCtD
Doxorubicin—ABCC1—Vincristine—kidney cancer	0.00402	0.0155	CbGbCtD
Doxorubicin—ABCC2—Paclitaxel—kidney cancer	0.00345	0.0133	CbGbCtD
Doxorubicin—ABCG2—Erlotinib—kidney cancer	0.00341	0.0132	CbGbCtD
Doxorubicin—ABCB1—Temsirolimus—kidney cancer	0.00328	0.0127	CbGbCtD
Doxorubicin—ABCG2—Paclitaxel—kidney cancer	0.00312	0.0121	CbGbCtD
Doxorubicin—CYP2D6—Temsirolimus—kidney cancer	0.00309	0.0119	CbGbCtD
Doxorubicin—ABCC2—Sorafenib—kidney cancer	0.00307	0.0119	CbGbCtD
Doxorubicin—ABCC2—Vinblastine—kidney cancer	0.00303	0.0117	CbGbCtD
Doxorubicin—ABCC2—Vincristine—kidney cancer	0.00298	0.0115	CbGbCtD
Doxorubicin—CYP3A4—Everolimus—kidney cancer	0.00291	0.0112	CbGbCtD
Doxorubicin—ABCG2—Sorafenib—kidney cancer	0.00277	0.0107	CbGbCtD
Doxorubicin—ABCG2—Vincristine—kidney cancer	0.00269	0.0104	CbGbCtD
Doxorubicin—ABCC2—Sunitinib—kidney cancer	0.00249	0.00961	CbGbCtD
Doxorubicin—ABCG2—Sunitinib—kidney cancer	0.00225	0.00868	CbGbCtD
Doxorubicin—CYP3A4—Temsirolimus—kidney cancer	0.00197	0.0076	CbGbCtD
Doxorubicin—CYP2B6—Sorafenib—kidney cancer	0.00195	0.00754	CbGbCtD
Doxorubicin—ABCB1—Pazopanib—kidney cancer	0.00172	0.00666	CbGbCtD
Doxorubicin—CYP2D6—Pazopanib—kidney cancer	0.00162	0.00628	CbGbCtD
Doxorubicin—ABCB1—Dactinomycin—kidney cancer	0.00158	0.00609	CbGbCtD
Doxorubicin—NOS3—nephron—kidney cancer	0.00145	0.0447	CbGeAlD
Doxorubicin—ABCB1—Gemcitabine—kidney cancer	0.00125	0.00482	CbGbCtD
Doxorubicin—ABCB1—Erlotinib—kidney cancer	0.00123	0.00475	CbGbCtD
Doxorubicin—CYP2D6—Erlotinib—kidney cancer	0.00116	0.00448	CbGbCtD
Doxorubicin—ABCB1—Paclitaxel—kidney cancer	0.00113	0.00435	CbGbCtD
Doxorubicin—Epirubicin—AURKA—kidney cancer	0.00105	0.811	CrCbGaD
Doxorubicin—CYP3A4—Pazopanib—kidney cancer	0.00103	0.00399	CbGbCtD
Doxorubicin—ABCB1—Sorafenib—kidney cancer	0.001	0.00386	CbGbCtD
Doxorubicin—ABCB1—Vinblastine—kidney cancer	0.000988	0.00382	CbGbCtD
Doxorubicin—ABCB1—Vincristine—kidney cancer	0.000971	0.00375	CbGbCtD
Doxorubicin—CYP2D6—Sorafenib—kidney cancer	0.000942	0.00364	CbGbCtD
Doxorubicin—CYP2D6—Vinblastine—kidney cancer	0.000931	0.0036	CbGbCtD
Doxorubicin—SLC22A16—renal system—kidney cancer	0.000856	0.0263	CbGeAlD
Doxorubicin—SLC22A16—kidney—kidney cancer	0.000828	0.0254	CbGeAlD
Doxorubicin—ABCB1—Sunitinib—kidney cancer	0.00081	0.00313	CbGbCtD
Doxorubicin—SLC22A16—gonad—kidney cancer	0.000768	0.0236	CbGeAlD
Doxorubicin—CYP3A4—Erlotinib—kidney cancer	0.000737	0.00285	CbGbCtD
Doxorubicin—CYP3A4—Paclitaxel—kidney cancer	0.000675	0.00261	CbGbCtD
Doxorubicin—ABCB8—renal system—kidney cancer	0.000666	0.0205	CbGeAlD
Doxorubicin—ABCB8—kidney—kidney cancer	0.000644	0.0198	CbGeAlD
Doxorubicin—CYP3A4—Sorafenib—kidney cancer	0.000599	0.00232	CbGbCtD
Doxorubicin—ABCB8—gonad—kidney cancer	0.000597	0.0184	CbGeAlD
Doxorubicin—CYP3A4—Vinblastine—kidney cancer	0.000592	0.00229	CbGbCtD
Doxorubicin—CYP3A4—Vincristine—kidney cancer	0.000582	0.00225	CbGbCtD
Doxorubicin—AKR1A1—nephron tubule—kidney cancer	0.000545	0.0167	CbGeAlD
Doxorubicin—NDUFS2—Everolimus—Temsirolimus—kidney cancer	0.000499	0.317	CbGdCrCtD
Doxorubicin—AKR1A1—renal system—kidney cancer	0.000495	0.0152	CbGeAlD
Doxorubicin—NDUFS7—nephron tubule—kidney cancer	0.000495	0.0152	CbGeAlD
Doxorubicin—CYP3A4—Sunitinib—kidney cancer	0.000486	0.00188	CbGbCtD
Doxorubicin—AKR1A1—kidney—kidney cancer	0.000479	0.0147	CbGeAlD
Doxorubicin—AKR1A1—cortex of kidney—kidney cancer	0.000466	0.0143	CbGeAlD
Doxorubicin—NDUFS7—renal system—kidney cancer	0.00045	0.0138	CbGeAlD
Doxorubicin—AKR1A1—gonad—kidney cancer	0.000444	0.0136	CbGeAlD
Doxorubicin—AKR1A1—cardiac atrium—kidney cancer	0.000443	0.0136	CbGeAlD
Doxorubicin—NDUFS7—kidney—kidney cancer	0.000435	0.0134	CbGeAlD
Doxorubicin—NDUFS7—cortex of kidney—kidney cancer	0.000424	0.013	CbGeAlD
Doxorubicin—AURKA—renal system—kidney cancer	0.000418	0.0129	CbGeAlD
Doxorubicin—NDUFS2—nephron tubule—kidney cancer	0.00041	0.0126	CbGeAlD
Doxorubicin—NDUFS3—nephron tubule—kidney cancer	0.000405	0.0124	CbGeAlD
Doxorubicin—AURKA—kidney—kidney cancer	0.000404	0.0124	CbGeAlD
Doxorubicin—NDUFS7—cardiac atrium—kidney cancer	0.000403	0.0124	CbGeAlD
Doxorubicin—DHCR7—nephron tubule—kidney cancer	0.000385	0.0118	CbGeAlD
Doxorubicin—NOS1—renal system—kidney cancer	0.000375	0.0115	CbGeAlD
Doxorubicin—AURKA—gonad—kidney cancer	0.000375	0.0115	CbGeAlD
Doxorubicin—NDUFS2—renal system—kidney cancer	0.000373	0.0115	CbGeAlD
Doxorubicin—NDUFS3—renal system—kidney cancer	0.000368	0.0113	CbGeAlD
Doxorubicin—NOS1—kidney—kidney cancer	0.000363	0.0111	CbGeAlD
Doxorubicin—NDUFS2—kidney—kidney cancer	0.00036	0.0111	CbGeAlD
Doxorubicin—NDUFS3—kidney—kidney cancer	0.000356	0.0109	CbGeAlD
Doxorubicin—NOS1—cortex of kidney—kidney cancer	0.000353	0.0109	CbGeAlD
Doxorubicin—NDUFS2—cortex of kidney—kidney cancer	0.000351	0.0108	CbGeAlD
Doxorubicin—NDUFS3—cortex of kidney—kidney cancer	0.000347	0.0107	CbGeAlD
Doxorubicin—ABCC6—renal system—kidney cancer	0.000341	0.0105	CbGeAlD
Doxorubicin—NOS1—gonad—kidney cancer	0.000336	0.0103	CbGeAlD
Doxorubicin—NDUFS2—gonad—kidney cancer	0.000334	0.0103	CbGeAlD
Doxorubicin—NDUFS2—cardiac atrium—kidney cancer	0.000334	0.0103	CbGeAlD
Doxorubicin—NDUFS3—gonad—kidney cancer	0.00033	0.0101	CbGeAlD
Doxorubicin—NDUFS3—cardiac atrium—kidney cancer	0.00033	0.0101	CbGeAlD
Doxorubicin—ABCC6—kidney—kidney cancer	0.00033	0.0101	CbGeAlD
Doxorubicin—DHCR7—cortex of kidney—kidney cancer	0.000329	0.0101	CbGeAlD
Doxorubicin—CYP3A4—urine—kidney cancer	0.000323	0.00992	CbGeAlD
Doxorubicin—YWHAG—renal system—kidney cancer	0.000321	0.00986	CbGeAlD
Doxorubicin—RALBP1—nephron tubule—kidney cancer	0.000319	0.0098	CbGeAlD
Doxorubicin—CYP2D6—urine—kidney cancer	0.000318	0.00976	CbGeAlD
Doxorubicin—DHCR7—gonad—kidney cancer	0.000314	0.00964	CbGeAlD
Doxorubicin—DHCR7—cardiac atrium—kidney cancer	0.000313	0.00963	CbGeAlD
Doxorubicin—XDH—renal system—kidney cancer	0.000313	0.00962	CbGeAlD
Doxorubicin—YWHAG—kidney—kidney cancer	0.00031	0.00954	CbGeAlD
Doxorubicin—XDH—kidney—kidney cancer	0.000303	0.0093	CbGeAlD
Doxorubicin—YWHAG—cortex of kidney—kidney cancer	0.000302	0.00929	CbGeAlD
Doxorubicin—CBR1—nephron tubule—kidney cancer	0.000298	0.00915	CbGeAlD
Doxorubicin—AKR1C3—nephron tubule—kidney cancer	0.000294	0.00904	CbGeAlD
Doxorubicin—RALBP1—renal system—kidney cancer	0.00029	0.00891	CbGeAlD
Doxorubicin—YWHAG—gonad—kidney cancer	0.000288	0.00885	CbGeAlD
Doxorubicin—YWHAG—cardiac atrium—kidney cancer	0.000287	0.00883	CbGeAlD
Doxorubicin—NOS3—renal system—kidney cancer	0.000285	0.00876	CbGeAlD
Doxorubicin—RALBP1—kidney—kidney cancer	0.00028	0.00861	CbGeAlD
Doxorubicin—NOS3—kidney—kidney cancer	0.000276	0.00847	CbGeAlD
Doxorubicin—RALBP1—cortex of kidney—kidney cancer	0.000273	0.00839	CbGeAlD
Doxorubicin—CBR1—renal system—kidney cancer	0.000271	0.00832	CbGeAlD
Doxorubicin—POR—nephron tubule—kidney cancer	0.000269	0.00825	CbGeAlD
Doxorubicin—CBR1—kidney—kidney cancer	0.000262	0.00804	CbGeAlD
Doxorubicin—RALBP1—cardiac atrium—kidney cancer	0.00026	0.00798	CbGeAlD
Doxorubicin—CBR1—cortex of kidney—kidney cancer	0.000255	0.00783	CbGeAlD
Doxorubicin—AKR1C3—cortex of kidney—kidney cancer	0.000252	0.00773	CbGeAlD
Doxorubicin—CBR1—gonad—kidney cancer	0.000243	0.00746	CbGeAlD
Doxorubicin—CBR1—cardiac atrium—kidney cancer	0.000242	0.00745	CbGeAlD
Doxorubicin—AKR1C3—cardiac atrium—kidney cancer	0.000239	0.00736	CbGeAlD
Doxorubicin—NQO1—nephron tubule—kidney cancer	0.000239	0.00733	CbGeAlD
Doxorubicin—POR—cortex of kidney—kidney cancer	0.00023	0.00706	CbGeAlD
Doxorubicin—POR—cardiac atrium—kidney cancer	0.000219	0.00672	CbGeAlD
Doxorubicin—NQO1—renal system—kidney cancer	0.000217	0.00666	CbGeAlD
Doxorubicin—NQO1—kidney—kidney cancer	0.00021	0.00644	CbGeAlD
Doxorubicin—NQO1—cortex of kidney—kidney cancer	0.000204	0.00627	CbGeAlD
Doxorubicin—ABCC3—renal system—kidney cancer	0.000195	0.00598	CbGeAlD
Doxorubicin—ABCC10—renal system—kidney cancer	0.000194	0.00595	CbGeAlD
Doxorubicin—ABCC3—kidney—kidney cancer	0.000188	0.00578	CbGeAlD
Doxorubicin—ABCC10—kidney—kidney cancer	0.000187	0.00575	CbGeAlD
Doxorubicin—ABCC10—cortex of kidney—kidney cancer	0.000182	0.0056	CbGeAlD
Doxorubicin—ABCC10—gonad—kidney cancer	0.000174	0.00534	CbGeAlD
Doxorubicin—ABCC10—cardiac atrium—kidney cancer	0.000173	0.00533	CbGeAlD
Doxorubicin—ABCC2—nephron tubule—kidney cancer	0.000171	0.00526	CbGeAlD
Doxorubicin—CYP1B1—nephron tubule—kidney cancer	0.000168	0.00515	CbGeAlD
Doxorubicin—Daunorubicin—CYP1A1—kidney cancer	0.000159	0.123	CrCbGaD
Doxorubicin—ABCC2—renal system—kidney cancer	0.000155	0.00478	CbGeAlD
Doxorubicin—CYP1B1—renal system—kidney cancer	0.000152	0.00468	CbGeAlD
Doxorubicin—ABCC2—kidney—kidney cancer	0.00015	0.00462	CbGeAlD
Doxorubicin—CYP1B1—kidney—kidney cancer	0.000147	0.00452	CbGeAlD
Doxorubicin—ABCC2—cortex of kidney—kidney cancer	0.000146	0.0045	CbGeAlD
Doxorubicin—CYP1B1—cortex of kidney—kidney cancer	0.000143	0.00441	CbGeAlD
Doxorubicin—CYP1B1—gonad—kidney cancer	0.000137	0.0042	CbGeAlD
Doxorubicin—ABCC1—cortex of kidney—kidney cancer	0.000129	0.00396	CbGeAlD
Doxorubicin—ABCG2—nephron tubule—kidney cancer	0.000125	0.00383	CbGeAlD
Doxorubicin—NQO1—Vincristine—Vinblastine—kidney cancer	0.000124	0.0787	CbGdCrCtD
Doxorubicin—ABCC1—cardiac atrium—kidney cancer	0.000123	0.00377	CbGeAlD
Doxorubicin—CYP2B6—nephron tubule—kidney cancer	0.000115	0.00354	CbGeAlD
Doxorubicin—CYP2B6—renal system—kidney cancer	0.000105	0.00321	CbGeAlD
Doxorubicin—CYP2B6—kidney—kidney cancer	0.000101	0.00311	CbGeAlD
Doxorubicin—AKR1C3—Vincristine—Vinblastine—kidney cancer	9.92e-05	0.063	CbGdCrCtD
Doxorubicin—AURKA—Temsirolimus—Everolimus—kidney cancer	9.43e-05	0.0598	CbGdCrCtD
Doxorubicin—AURKA—Sirolimus—Temsirolimus—kidney cancer	9.43e-05	0.0598	CbGdCrCtD
Doxorubicin—AURKA—Sirolimus—Everolimus—kidney cancer	9.43e-05	0.0598	CbGdCrCtD
Doxorubicin—CYP2B6—gonad—kidney cancer	9.38e-05	0.00288	CbGeAlD
Doxorubicin—Daunorubicin—ABCB1—kidney cancer	8.47e-05	0.0656	CrCbGaD
Doxorubicin—AKR1C3—Vinblastine—Vincristine—kidney cancer	7.97e-05	0.0506	CbGdCrCtD
Doxorubicin—CYP3A4—renal system—kidney cancer	7.9e-05	0.00243	CbGeAlD
Doxorubicin—CYP2D6—renal system—kidney cancer	7.77e-05	0.00239	CbGeAlD
Doxorubicin—CYP3A4—kidney—kidney cancer	7.64e-05	0.00235	CbGeAlD
Doxorubicin—CBR1—Vincristine—Vinblastine—kidney cancer	7.57e-05	0.0481	CbGdCrCtD
Doxorubicin—CYP2D6—kidney—kidney cancer	7.52e-05	0.00231	CbGeAlD
Doxorubicin—TOP2A—Docetaxel—Paclitaxel—kidney cancer	7.5e-05	0.0476	CbGdCrCtD
Doxorubicin—ABCB1—nephron tubule—kidney cancer	6.15e-05	0.00189	CbGeAlD
Doxorubicin—ABCB1—renal system—kidney cancer	5.59e-05	0.00172	CbGeAlD
Doxorubicin—ABCB1—kidney—kidney cancer	5.41e-05	0.00166	CbGeAlD
Doxorubicin—ABCB1—cortex of kidney—kidney cancer	5.26e-05	0.00162	CbGeAlD
Doxorubicin—ABCB1—gonad—kidney cancer	5.01e-05	0.00154	CbGeAlD
Doxorubicin—CBR3—Azacitidine—Gemcitabine—kidney cancer	4.81e-05	0.0306	CbGdCrCtD
Doxorubicin—TOP2A—Vindesine—Vinblastine—kidney cancer	3.81e-05	0.0242	CbGdCrCtD
Doxorubicin—TOP2A—Vindesine—Vincristine—kidney cancer	3.81e-05	0.0242	CbGdCrCtD
Doxorubicin—TOP2A—Gefitinib—Erlotinib—kidney cancer	3.59e-05	0.0228	CbGdCrCtD
Doxorubicin—CBR1—Azacitidine—Gemcitabine—kidney cancer	3.57e-05	0.0226	CbGdCrCtD
Doxorubicin—AURKA—Cytarabine—Gemcitabine—kidney cancer	3.54e-05	0.0225	CbGdCrCtD
Doxorubicin—TOP2A—Vinorelbine—Vinblastine—kidney cancer	2.41e-05	0.0153	CbGdCrCtD
Doxorubicin—TOP2A—Vinorelbine—Vincristine—kidney cancer	2.41e-05	0.0153	CbGdCrCtD
Doxorubicin—TOP2A—Vincristine—Vinblastine—kidney cancer	2.06e-05	0.0131	CbGdCrCtD
Doxorubicin—TOP2A—Vinblastine—Vincristine—kidney cancer	1.65e-05	0.0105	CbGdCrCtD
Doxorubicin—Flatulence—Paclitaxel—kidney cancer	1.56e-05	0.00018	CcSEcCtD
Doxorubicin—Pain—Dactinomycin—kidney cancer	1.56e-05	0.00018	CcSEcCtD
Doxorubicin—Tension—Paclitaxel—kidney cancer	1.55e-05	0.000179	CcSEcCtD
Doxorubicin—Agranulocytosis—Capecitabine—kidney cancer	1.55e-05	0.000179	CcSEcCtD
Doxorubicin—Anorexia—Vincristine—kidney cancer	1.55e-05	0.000179	CcSEcCtD
Doxorubicin—Dysgeusia—Paclitaxel—kidney cancer	1.55e-05	0.000179	CcSEcCtD
Doxorubicin—Oedema—Gemcitabine—kidney cancer	1.54e-05	0.000178	CcSEcCtD
Doxorubicin—Anaphylactic shock—Gemcitabine—kidney cancer	1.54e-05	0.000178	CcSEcCtD
Doxorubicin—Nervousness—Paclitaxel—kidney cancer	1.54e-05	0.000178	CcSEcCtD
Doxorubicin—Infection—Gemcitabine—kidney cancer	1.53e-05	0.000177	CcSEcCtD
Doxorubicin—Back pain—Paclitaxel—kidney cancer	1.53e-05	0.000177	CcSEcCtD
Doxorubicin—Dizziness—Vinblastine—kidney cancer	1.53e-05	0.000177	CcSEcCtD
Doxorubicin—Dizziness—Everolimus—kidney cancer	1.52e-05	0.000176	CcSEcCtD
Doxorubicin—Muscle spasms—Paclitaxel—kidney cancer	1.52e-05	0.000176	CcSEcCtD
Doxorubicin—Abdominal pain—Sunitinib—kidney cancer	1.52e-05	0.000176	CcSEcCtD
Doxorubicin—Body temperature increased—Sunitinib—kidney cancer	1.52e-05	0.000176	CcSEcCtD
Doxorubicin—Diarrhoea—Erlotinib—kidney cancer	1.52e-05	0.000176	CcSEcCtD
Doxorubicin—Hypotension—Vincristine—kidney cancer	1.52e-05	0.000176	CcSEcCtD
Doxorubicin—Bradycardia—Capecitabine—kidney cancer	1.52e-05	0.000176	CcSEcCtD
Doxorubicin—Nervous system disorder—Gemcitabine—kidney cancer	1.51e-05	0.000175	CcSEcCtD
Doxorubicin—Thrombocytopenia—Gemcitabine—kidney cancer	1.51e-05	0.000175	CcSEcCtD
Doxorubicin—Feeling abnormal—Dactinomycin—kidney cancer	1.5e-05	0.000173	CcSEcCtD
Doxorubicin—Haemoglobin—Capecitabine—kidney cancer	1.5e-05	0.000173	CcSEcCtD
Doxorubicin—Skin disorder—Gemcitabine—kidney cancer	1.5e-05	0.000173	CcSEcCtD
Doxorubicin—Rhinitis—Capecitabine—kidney cancer	1.49e-05	0.000173	CcSEcCtD
Doxorubicin—Haemorrhage—Capecitabine—kidney cancer	1.49e-05	0.000172	CcSEcCtD
Doxorubicin—Hepatitis—Capecitabine—kidney cancer	1.49e-05	0.000172	CcSEcCtD
Doxorubicin—Vision blurred—Paclitaxel—kidney cancer	1.49e-05	0.000172	CcSEcCtD
Doxorubicin—Hyperhidrosis—Gemcitabine—kidney cancer	1.49e-05	0.000172	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Dactinomycin—kidney cancer	1.49e-05	0.000172	CcSEcCtD
Doxorubicin—Hypoaesthesia—Capecitabine—kidney cancer	1.48e-05	0.000172	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Vincristine—kidney cancer	1.48e-05	0.000171	CcSEcCtD
Doxorubicin—Pharyngitis—Capecitabine—kidney cancer	1.48e-05	0.000171	CcSEcCtD
Doxorubicin—Urinary tract disorder—Capecitabine—kidney cancer	1.47e-05	0.00017	CcSEcCtD
Doxorubicin—Hypersensitivity—Sorafenib—kidney cancer	1.47e-05	0.00017	CcSEcCtD
Doxorubicin—Insomnia—Vincristine—kidney cancer	1.47e-05	0.00017	CcSEcCtD
Doxorubicin—Anorexia—Gemcitabine—kidney cancer	1.47e-05	0.00017	CcSEcCtD
Doxorubicin—Oedema peripheral—Capecitabine—kidney cancer	1.47e-05	0.00017	CcSEcCtD
Doxorubicin—Vomiting—Vinblastine—kidney cancer	1.47e-05	0.00017	CcSEcCtD
Doxorubicin—Dizziness—Erlotinib—kidney cancer	1.47e-05	0.00017	CcSEcCtD
Doxorubicin—Ill-defined disorder—Paclitaxel—kidney cancer	1.47e-05	0.00017	CcSEcCtD
Doxorubicin—Connective tissue disorder—Capecitabine—kidney cancer	1.46e-05	0.000169	CcSEcCtD
Doxorubicin—Vomiting—Everolimus—kidney cancer	1.46e-05	0.000169	CcSEcCtD
Doxorubicin—Anaemia—Paclitaxel—kidney cancer	1.46e-05	0.000169	CcSEcCtD
Doxorubicin—Urethral disorder—Capecitabine—kidney cancer	1.46e-05	0.000169	CcSEcCtD
Doxorubicin—Paraesthesia—Vincristine—kidney cancer	1.46e-05	0.000169	CcSEcCtD
Doxorubicin—Agitation—Paclitaxel—kidney cancer	1.45e-05	0.000168	CcSEcCtD
Doxorubicin—Rash—Everolimus—kidney cancer	1.45e-05	0.000168	CcSEcCtD
Doxorubicin—Dermatitis—Everolimus—kidney cancer	1.45e-05	0.000168	CcSEcCtD
Doxorubicin—Headache—Vinblastine—kidney cancer	1.45e-05	0.000167	CcSEcCtD
Doxorubicin—Headache—Everolimus—kidney cancer	1.44e-05	0.000167	CcSEcCtD
Doxorubicin—Hypotension—Gemcitabine—kidney cancer	1.44e-05	0.000167	CcSEcCtD
Doxorubicin—Abdominal pain—Dactinomycin—kidney cancer	1.44e-05	0.000166	CcSEcCtD
Doxorubicin—Body temperature increased—Dactinomycin—kidney cancer	1.44e-05	0.000166	CcSEcCtD
Doxorubicin—Visual impairment—Capecitabine—kidney cancer	1.44e-05	0.000166	CcSEcCtD
Doxorubicin—Asthenia—Sorafenib—kidney cancer	1.43e-05	0.000166	CcSEcCtD
Doxorubicin—Malaise—Paclitaxel—kidney cancer	1.43e-05	0.000165	CcSEcCtD
Doxorubicin—Vertigo—Paclitaxel—kidney cancer	1.42e-05	0.000164	CcSEcCtD
Doxorubicin—Syncope—Paclitaxel—kidney cancer	1.42e-05	0.000164	CcSEcCtD
Doxorubicin—Leukopenia—Paclitaxel—kidney cancer	1.42e-05	0.000164	CcSEcCtD
Doxorubicin—Hypersensitivity—Sunitinib—kidney cancer	1.42e-05	0.000164	CcSEcCtD
Doxorubicin—Decreased appetite—Vincristine—kidney cancer	1.41e-05	0.000163	CcSEcCtD
Doxorubicin—Pruritus—Sorafenib—kidney cancer	1.41e-05	0.000163	CcSEcCtD
Doxorubicin—Vomiting—Erlotinib—kidney cancer	1.41e-05	0.000163	CcSEcCtD
Doxorubicin—Erythema multiforme—Capecitabine—kidney cancer	1.41e-05	0.000163	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	1.4e-05	0.000162	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Vincristine—kidney cancer	1.4e-05	0.000162	CcSEcCtD
Doxorubicin—Fatigue—Vincristine—kidney cancer	1.4e-05	0.000162	CcSEcCtD
Doxorubicin—Rash—Erlotinib—kidney cancer	1.4e-05	0.000162	CcSEcCtD
Doxorubicin—Dermatitis—Erlotinib—kidney cancer	1.4e-05	0.000162	CcSEcCtD
Doxorubicin—Palpitations—Paclitaxel—kidney cancer	1.4e-05	0.000162	CcSEcCtD
Doxorubicin—Insomnia—Gemcitabine—kidney cancer	1.39e-05	0.000161	CcSEcCtD
Doxorubicin—Eye disorder—Capecitabine—kidney cancer	1.39e-05	0.000161	CcSEcCtD
Doxorubicin—Headache—Erlotinib—kidney cancer	1.39e-05	0.000161	CcSEcCtD
Doxorubicin—Tinnitus—Capecitabine—kidney cancer	1.39e-05	0.000161	CcSEcCtD
Doxorubicin—Loss of consciousness—Paclitaxel—kidney cancer	1.39e-05	0.000161	CcSEcCtD
Doxorubicin—Pain—Vincristine—kidney cancer	1.39e-05	0.000161	CcSEcCtD
Doxorubicin—Constipation—Vincristine—kidney cancer	1.39e-05	0.000161	CcSEcCtD
Doxorubicin—Paraesthesia—Gemcitabine—kidney cancer	1.38e-05	0.00016	CcSEcCtD
Doxorubicin—Flushing—Capecitabine—kidney cancer	1.38e-05	0.00016	CcSEcCtD
Doxorubicin—Cardiac disorder—Capecitabine—kidney cancer	1.38e-05	0.00016	CcSEcCtD
Doxorubicin—Cough—Paclitaxel—kidney cancer	1.38e-05	0.00016	CcSEcCtD
Doxorubicin—Asthenia—Sunitinib—kidney cancer	1.38e-05	0.000159	CcSEcCtD
Doxorubicin—Dyspnoea—Gemcitabine—kidney cancer	1.37e-05	0.000159	CcSEcCtD
Doxorubicin—Nausea—Vinblastine—kidney cancer	1.37e-05	0.000159	CcSEcCtD
Doxorubicin—Somnolence—Gemcitabine—kidney cancer	1.37e-05	0.000159	CcSEcCtD
Doxorubicin—Convulsion—Paclitaxel—kidney cancer	1.37e-05	0.000158	CcSEcCtD
Doxorubicin—Nausea—Everolimus—kidney cancer	1.37e-05	0.000158	CcSEcCtD
Doxorubicin—Diarrhoea—Sorafenib—kidney cancer	1.37e-05	0.000158	CcSEcCtD
Doxorubicin—Hypertension—Paclitaxel—kidney cancer	1.37e-05	0.000158	CcSEcCtD
Doxorubicin—Pruritus—Sunitinib—kidney cancer	1.36e-05	0.000157	CcSEcCtD
Doxorubicin—Angiopathy—Capecitabine—kidney cancer	1.35e-05	0.000156	CcSEcCtD
Doxorubicin—TOP2A—Cytarabine—Gemcitabine—kidney cancer	1.35e-05	0.00858	CbGdCrCtD
Doxorubicin—Immune system disorder—Capecitabine—kidney cancer	1.35e-05	0.000156	CcSEcCtD
Doxorubicin—Arthralgia—Paclitaxel—kidney cancer	1.35e-05	0.000156	CcSEcCtD
Doxorubicin—Chest pain—Paclitaxel—kidney cancer	1.35e-05	0.000156	CcSEcCtD
Doxorubicin—Myalgia—Paclitaxel—kidney cancer	1.35e-05	0.000156	CcSEcCtD
Doxorubicin—Mediastinal disorder—Capecitabine—kidney cancer	1.34e-05	0.000155	CcSEcCtD
Doxorubicin—Anxiety—Paclitaxel—kidney cancer	1.34e-05	0.000155	CcSEcCtD
Doxorubicin—Decreased appetite—Gemcitabine—kidney cancer	1.34e-05	0.000155	CcSEcCtD
Doxorubicin—Hypersensitivity—Dactinomycin—kidney cancer	1.34e-05	0.000155	CcSEcCtD
Doxorubicin—Chills—Capecitabine—kidney cancer	1.34e-05	0.000155	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	1.34e-05	0.000155	CcSEcCtD
Doxorubicin—Arrhythmia—Capecitabine—kidney cancer	1.33e-05	0.000154	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Gemcitabine—kidney cancer	1.33e-05	0.000154	CcSEcCtD
Doxorubicin—Discomfort—Paclitaxel—kidney cancer	1.33e-05	0.000154	CcSEcCtD
Doxorubicin—Fatigue—Gemcitabine—kidney cancer	1.33e-05	0.000154	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Vincristine—kidney cancer	1.33e-05	0.000154	CcSEcCtD
Doxorubicin—Dizziness—Sorafenib—kidney cancer	1.32e-05	0.000153	CcSEcCtD
Doxorubicin—Pain—Gemcitabine—kidney cancer	1.32e-05	0.000152	CcSEcCtD
Doxorubicin—Constipation—Gemcitabine—kidney cancer	1.32e-05	0.000152	CcSEcCtD
Doxorubicin—Nausea—Erlotinib—kidney cancer	1.32e-05	0.000152	CcSEcCtD
Doxorubicin—Alopecia—Capecitabine—kidney cancer	1.32e-05	0.000152	CcSEcCtD
Doxorubicin—Dry mouth—Paclitaxel—kidney cancer	1.32e-05	0.000152	CcSEcCtD
Doxorubicin—Diarrhoea—Sunitinib—kidney cancer	1.31e-05	0.000152	CcSEcCtD
Doxorubicin—Mental disorder—Capecitabine—kidney cancer	1.31e-05	0.000151	CcSEcCtD
Doxorubicin—Asthenia—Dactinomycin—kidney cancer	1.3e-05	0.000151	CcSEcCtD
Doxorubicin—Confusional state—Paclitaxel—kidney cancer	1.3e-05	0.000151	CcSEcCtD
Doxorubicin—Malnutrition—Capecitabine—kidney cancer	1.3e-05	0.00015	CcSEcCtD
Doxorubicin—Erythema—Capecitabine—kidney cancer	1.3e-05	0.00015	CcSEcCtD
Doxorubicin—Oedema—Paclitaxel—kidney cancer	1.29e-05	0.000149	CcSEcCtD
Doxorubicin—Anaphylactic shock—Paclitaxel—kidney cancer	1.29e-05	0.000149	CcSEcCtD
Doxorubicin—Abdominal pain—Vincristine—kidney cancer	1.28e-05	0.000149	CcSEcCtD
Doxorubicin—Body temperature increased—Vincristine—kidney cancer	1.28e-05	0.000149	CcSEcCtD
Doxorubicin—Infection—Paclitaxel—kidney cancer	1.28e-05	0.000148	CcSEcCtD
Doxorubicin—Flatulence—Capecitabine—kidney cancer	1.28e-05	0.000148	CcSEcCtD
Doxorubicin—Dysgeusia—Capecitabine—kidney cancer	1.27e-05	0.000147	CcSEcCtD
Doxorubicin—Dizziness—Sunitinib—kidney cancer	1.27e-05	0.000147	CcSEcCtD
Doxorubicin—Feeling abnormal—Gemcitabine—kidney cancer	1.27e-05	0.000147	CcSEcCtD
Doxorubicin—Shock—Paclitaxel—kidney cancer	1.27e-05	0.000147	CcSEcCtD
Doxorubicin—Vomiting—Sorafenib—kidney cancer	1.27e-05	0.000147	CcSEcCtD
Doxorubicin—Nervous system disorder—Paclitaxel—kidney cancer	1.27e-05	0.000146	CcSEcCtD
Doxorubicin—Thrombocytopenia—Paclitaxel—kidney cancer	1.26e-05	0.000146	CcSEcCtD
Doxorubicin—Tachycardia—Paclitaxel—kidney cancer	1.26e-05	0.000146	CcSEcCtD
Doxorubicin—Rash—Sorafenib—kidney cancer	1.26e-05	0.000146	CcSEcCtD
Doxorubicin—Dermatitis—Sorafenib—kidney cancer	1.26e-05	0.000145	CcSEcCtD
Doxorubicin—Back pain—Capecitabine—kidney cancer	1.26e-05	0.000145	CcSEcCtD
Doxorubicin—Skin disorder—Paclitaxel—kidney cancer	1.25e-05	0.000145	CcSEcCtD
Doxorubicin—Headache—Sorafenib—kidney cancer	1.25e-05	0.000145	CcSEcCtD
Doxorubicin—Muscle spasms—Capecitabine—kidney cancer	1.25e-05	0.000144	CcSEcCtD
Doxorubicin—Hyperhidrosis—Paclitaxel—kidney cancer	1.25e-05	0.000144	CcSEcCtD
Doxorubicin—Diarrhoea—Dactinomycin—kidney cancer	1.24e-05	0.000144	CcSEcCtD
Doxorubicin—Anorexia—Paclitaxel—kidney cancer	1.23e-05	0.000142	CcSEcCtD
Doxorubicin—Vision blurred—Capecitabine—kidney cancer	1.22e-05	0.000141	CcSEcCtD
Doxorubicin—Vomiting—Sunitinib—kidney cancer	1.22e-05	0.000141	CcSEcCtD
Doxorubicin—Body temperature increased—Gemcitabine—kidney cancer	1.22e-05	0.000141	CcSEcCtD
Doxorubicin—Rash—Sunitinib—kidney cancer	1.21e-05	0.00014	CcSEcCtD
Doxorubicin—Dermatitis—Sunitinib—kidney cancer	1.21e-05	0.00014	CcSEcCtD
Doxorubicin—Hypotension—Paclitaxel—kidney cancer	1.21e-05	0.000139	CcSEcCtD
Doxorubicin—Ill-defined disorder—Capecitabine—kidney cancer	1.2e-05	0.000139	CcSEcCtD
Doxorubicin—Headache—Sunitinib—kidney cancer	1.2e-05	0.000139	CcSEcCtD
Doxorubicin—Anaemia—Capecitabine—kidney cancer	1.2e-05	0.000139	CcSEcCtD
Doxorubicin—Hypersensitivity—Vincristine—kidney cancer	1.2e-05	0.000138	CcSEcCtD
Doxorubicin—Nausea—Sorafenib—kidney cancer	1.19e-05	0.000137	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	1.18e-05	0.000136	CcSEcCtD
Doxorubicin—Malaise—Capecitabine—kidney cancer	1.17e-05	0.000135	CcSEcCtD
Doxorubicin—Insomnia—Paclitaxel—kidney cancer	1.17e-05	0.000135	CcSEcCtD
Doxorubicin—Vertigo—Capecitabine—kidney cancer	1.17e-05	0.000135	CcSEcCtD
Doxorubicin—Asthenia—Vincristine—kidney cancer	1.17e-05	0.000135	CcSEcCtD
Doxorubicin—Syncope—Capecitabine—kidney cancer	1.16e-05	0.000135	CcSEcCtD
Doxorubicin—Leukopenia—Capecitabine—kidney cancer	1.16e-05	0.000134	CcSEcCtD
Doxorubicin—Paraesthesia—Paclitaxel—kidney cancer	1.16e-05	0.000134	CcSEcCtD
Doxorubicin—Vomiting—Dactinomycin—kidney cancer	1.16e-05	0.000134	CcSEcCtD
Doxorubicin—Dyspnoea—Paclitaxel—kidney cancer	1.15e-05	0.000133	CcSEcCtD
Doxorubicin—Somnolence—Paclitaxel—kidney cancer	1.15e-05	0.000133	CcSEcCtD
Doxorubicin—Palpitations—Capecitabine—kidney cancer	1.15e-05	0.000133	CcSEcCtD
Doxorubicin—Rash—Dactinomycin—kidney cancer	1.15e-05	0.000133	CcSEcCtD
Doxorubicin—Nausea—Sunitinib—kidney cancer	1.14e-05	0.000132	CcSEcCtD
Doxorubicin—Loss of consciousness—Capecitabine—kidney cancer	1.14e-05	0.000132	CcSEcCtD
Doxorubicin—Dyspepsia—Paclitaxel—kidney cancer	1.14e-05	0.000131	CcSEcCtD
Doxorubicin—Cough—Capecitabine—kidney cancer	1.13e-05	0.000131	CcSEcCtD
Doxorubicin—Decreased appetite—Paclitaxel—kidney cancer	1.12e-05	0.00013	CcSEcCtD
Doxorubicin—Hypertension—Capecitabine—kidney cancer	1.12e-05	0.00013	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Paclitaxel—kidney cancer	1.11e-05	0.000129	CcSEcCtD
Doxorubicin—Fatigue—Paclitaxel—kidney cancer	1.11e-05	0.000129	CcSEcCtD
Doxorubicin—Diarrhoea—Vincristine—kidney cancer	1.11e-05	0.000129	CcSEcCtD
Doxorubicin—Asthenia—Gemcitabine—kidney cancer	1.11e-05	0.000128	CcSEcCtD
Doxorubicin—Chest pain—Capecitabine—kidney cancer	1.1e-05	0.000128	CcSEcCtD
Doxorubicin—Arthralgia—Capecitabine—kidney cancer	1.1e-05	0.000128	CcSEcCtD
Doxorubicin—Myalgia—Capecitabine—kidney cancer	1.1e-05	0.000128	CcSEcCtD
Doxorubicin—Constipation—Paclitaxel—kidney cancer	1.1e-05	0.000128	CcSEcCtD
Doxorubicin—Pain—Paclitaxel—kidney cancer	1.1e-05	0.000128	CcSEcCtD
Doxorubicin—Anxiety—Capecitabine—kidney cancer	1.1e-05	0.000127	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	1.1e-05	0.000127	CcSEcCtD
Doxorubicin—Discomfort—Capecitabine—kidney cancer	1.09e-05	0.000126	CcSEcCtD
Doxorubicin—Pruritus—Gemcitabine—kidney cancer	1.09e-05	0.000126	CcSEcCtD
Doxorubicin—Dry mouth—Capecitabine—kidney cancer	1.08e-05	0.000125	CcSEcCtD
Doxorubicin—Nausea—Dactinomycin—kidney cancer	1.08e-05	0.000125	CcSEcCtD
Doxorubicin—Dizziness—Vincristine—kidney cancer	1.07e-05	0.000124	CcSEcCtD
Doxorubicin—Confusional state—Capecitabine—kidney cancer	1.07e-05	0.000124	CcSEcCtD
Doxorubicin—Feeling abnormal—Paclitaxel—kidney cancer	1.06e-05	0.000123	CcSEcCtD
Doxorubicin—Oedema—Capecitabine—kidney cancer	1.06e-05	0.000123	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Paclitaxel—kidney cancer	1.06e-05	0.000122	CcSEcCtD
Doxorubicin—Diarrhoea—Gemcitabine—kidney cancer	1.05e-05	0.000122	CcSEcCtD
Doxorubicin—Infection—Capecitabine—kidney cancer	1.05e-05	0.000122	CcSEcCtD
Doxorubicin—Shock—Capecitabine—kidney cancer	1.04e-05	0.000121	CcSEcCtD
Doxorubicin—Nervous system disorder—Capecitabine—kidney cancer	1.04e-05	0.00012	CcSEcCtD
Doxorubicin—Thrombocytopenia—Capecitabine—kidney cancer	1.04e-05	0.00012	CcSEcCtD
Doxorubicin—Tachycardia—Capecitabine—kidney cancer	1.03e-05	0.00012	CcSEcCtD
Doxorubicin—Vomiting—Vincristine—kidney cancer	1.03e-05	0.00012	CcSEcCtD
Doxorubicin—Skin disorder—Capecitabine—kidney cancer	1.03e-05	0.000119	CcSEcCtD
Doxorubicin—Urticaria—Paclitaxel—kidney cancer	1.03e-05	0.000119	CcSEcCtD
Doxorubicin—Rash—Vincristine—kidney cancer	1.02e-05	0.000119	CcSEcCtD
Doxorubicin—Hyperhidrosis—Capecitabine—kidney cancer	1.02e-05	0.000118	CcSEcCtD
Doxorubicin—Dermatitis—Vincristine—kidney cancer	1.02e-05	0.000118	CcSEcCtD
Doxorubicin—Body temperature increased—Paclitaxel—kidney cancer	1.02e-05	0.000118	CcSEcCtD
Doxorubicin—Abdominal pain—Paclitaxel—kidney cancer	1.02e-05	0.000118	CcSEcCtD
Doxorubicin—Headache—Vincristine—kidney cancer	1.02e-05	0.000118	CcSEcCtD
Doxorubicin—Anorexia—Capecitabine—kidney cancer	1.01e-05	0.000117	CcSEcCtD
Doxorubicin—Hypotension—Capecitabine—kidney cancer	9.9e-06	0.000114	CcSEcCtD
Doxorubicin—Vomiting—Gemcitabine—kidney cancer	9.8e-06	0.000113	CcSEcCtD
Doxorubicin—Rash—Gemcitabine—kidney cancer	9.72e-06	0.000112	CcSEcCtD
Doxorubicin—Dermatitis—Gemcitabine—kidney cancer	9.71e-06	0.000112	CcSEcCtD
Doxorubicin—TOP2A—Azacitidine—Gemcitabine—kidney cancer	9.69e-06	0.00615	CbGdCrCtD
Doxorubicin—Headache—Gemcitabine—kidney cancer	9.66e-06	0.000112	CcSEcCtD
Doxorubicin—Nausea—Vincristine—kidney cancer	9.65e-06	0.000112	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.65e-06	0.000112	CcSEcCtD
Doxorubicin—Insomnia—Capecitabine—kidney cancer	9.58e-06	0.000111	CcSEcCtD
Doxorubicin—Paraesthesia—Capecitabine—kidney cancer	9.51e-06	0.00011	CcSEcCtD
Doxorubicin—Hypersensitivity—Paclitaxel—kidney cancer	9.51e-06	0.00011	CcSEcCtD
Doxorubicin—Dyspnoea—Capecitabine—kidney cancer	9.44e-06	0.000109	CcSEcCtD
Doxorubicin—Dyspepsia—Capecitabine—kidney cancer	9.32e-06	0.000108	CcSEcCtD
Doxorubicin—Asthenia—Paclitaxel—kidney cancer	9.26e-06	0.000107	CcSEcCtD
Doxorubicin—Decreased appetite—Capecitabine—kidney cancer	9.21e-06	0.000106	CcSEcCtD
Doxorubicin—Nausea—Gemcitabine—kidney cancer	9.16e-06	0.000106	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Capecitabine—kidney cancer	9.14e-06	0.000106	CcSEcCtD
Doxorubicin—Fatigue—Capecitabine—kidney cancer	9.13e-06	0.000106	CcSEcCtD
Doxorubicin—Pruritus—Paclitaxel—kidney cancer	9.13e-06	0.000106	CcSEcCtD
Doxorubicin—Pain—Capecitabine—kidney cancer	9.06e-06	0.000105	CcSEcCtD
Doxorubicin—Constipation—Capecitabine—kidney cancer	9.06e-06	0.000105	CcSEcCtD
Doxorubicin—Diarrhoea—Paclitaxel—kidney cancer	8.83e-06	0.000102	CcSEcCtD
Doxorubicin—Feeling abnormal—Capecitabine—kidney cancer	8.73e-06	0.000101	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Capecitabine—kidney cancer	8.66e-06	0.0001	CcSEcCtD
Doxorubicin—Dizziness—Paclitaxel—kidney cancer	8.53e-06	9.87e-05	CcSEcCtD
Doxorubicin—Urticaria—Capecitabine—kidney cancer	8.41e-06	9.73e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Capecitabine—kidney cancer	8.37e-06	9.68e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Capecitabine—kidney cancer	8.37e-06	9.68e-05	CcSEcCtD
Doxorubicin—Vomiting—Paclitaxel—kidney cancer	8.21e-06	9.49e-05	CcSEcCtD
Doxorubicin—Rash—Paclitaxel—kidney cancer	8.14e-06	9.41e-05	CcSEcCtD
Doxorubicin—Dermatitis—Paclitaxel—kidney cancer	8.13e-06	9.4e-05	CcSEcCtD
Doxorubicin—Headache—Paclitaxel—kidney cancer	8.08e-06	9.35e-05	CcSEcCtD
Doxorubicin—Hypersensitivity—Capecitabine—kidney cancer	7.8e-06	9.03e-05	CcSEcCtD
Doxorubicin—Nausea—Paclitaxel—kidney cancer	7.67e-06	8.87e-05	CcSEcCtD
Doxorubicin—Asthenia—Capecitabine—kidney cancer	7.6e-06	8.79e-05	CcSEcCtD
Doxorubicin—Pruritus—Capecitabine—kidney cancer	7.49e-06	8.67e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Capecitabine—kidney cancer	7.25e-06	8.38e-05	CcSEcCtD
Doxorubicin—Dizziness—Capecitabine—kidney cancer	7e-06	8.1e-05	CcSEcCtD
Doxorubicin—Vomiting—Capecitabine—kidney cancer	6.73e-06	7.79e-05	CcSEcCtD
Doxorubicin—Rash—Capecitabine—kidney cancer	6.68e-06	7.72e-05	CcSEcCtD
Doxorubicin—Dermatitis—Capecitabine—kidney cancer	6.67e-06	7.72e-05	CcSEcCtD
Doxorubicin—Headache—Capecitabine—kidney cancer	6.63e-06	7.67e-05	CcSEcCtD
Doxorubicin—Nausea—Capecitabine—kidney cancer	6.29e-06	7.28e-05	CcSEcCtD
Doxorubicin—AKR1C3—Signaling Pathways—APC—kidney cancer	2.1e-06	4.32e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—BCHE—kidney cancer	2.09e-06	4.31e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.08e-06	4.29e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MYC—kidney cancer	2.08e-06	4.29e-05	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PIK3CA—kidney cancer	2.08e-06	4.28e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LDHB—kidney cancer	2.08e-06	4.28e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CRABP1—kidney cancer	2.08e-06	4.27e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SLC5A5—kidney cancer	2.07e-06	4.25e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MAPK1—kidney cancer	2.04e-06	4.19e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CTNNB1—kidney cancer	2.03e-06	4.19e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PIK3CA—kidney cancer	2.02e-06	4.15e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—POMC—kidney cancer	2.02e-06	4.15e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HIF1A—kidney cancer	2.01e-06	4.14e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TSC2—kidney cancer	2.01e-06	4.13e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC5A3—kidney cancer	2e-06	4.11e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PGK1—kidney cancer	2e-06	4.11e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SLC2A1—kidney cancer	2e-06	4.11e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—POMC—kidney cancer	2e-06	4.11e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CCBL1—kidney cancer	1.99e-06	4.09e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—RAF1—kidney cancer	1.99e-06	4.09e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTEN—kidney cancer	1.98e-06	4.08e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.97e-06	4.07e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGS2—kidney cancer	1.97e-06	4.06e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—BRAF—kidney cancer	1.97e-06	4.06e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ERBB2—kidney cancer	1.96e-06	4.04e-05	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—kidney cancer	1.96e-06	4.04e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LDHB—kidney cancer	1.96e-06	4.03e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MTOR—kidney cancer	1.94e-06	3.99e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD4—kidney cancer	1.93e-06	3.98e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ITPR2—kidney cancer	1.93e-06	3.97e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—KRAS—kidney cancer	1.92e-06	3.96e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KDR—kidney cancer	1.92e-06	3.96e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTGS2—kidney cancer	1.92e-06	3.95e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.92e-06	3.95e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—kidney cancer	1.9e-06	3.92e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.9e-06	3.92e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GSTP1—kidney cancer	1.89e-06	3.89e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.87e-06	3.85e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.86e-06	3.82e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MAPK3—kidney cancer	1.84e-06	3.79e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GSTP1—kidney cancer	1.83e-06	3.77e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CDKN1B—kidney cancer	1.82e-06	3.74e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.82e-06	3.74e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.8e-06	3.71e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CA9—kidney cancer	1.8e-06	3.71e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MYC—kidney cancer	1.79e-06	3.69e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ABCB1—kidney cancer	1.79e-06	3.69e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.78e-06	3.66e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KIT—kidney cancer	1.77e-06	3.65e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—APC—kidney cancer	1.77e-06	3.65e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—kidney cancer	1.77e-06	3.64e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PIK3CA—kidney cancer	1.77e-06	3.64e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ACHE—kidney cancer	1.76e-06	3.62e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTT1—kidney cancer	1.76e-06	3.62e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MAPK1—kidney cancer	1.75e-06	3.61e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HIF1A—kidney cancer	1.75e-06	3.6e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TSC2—kidney cancer	1.75e-06	3.59e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GSTM1—kidney cancer	1.74e-06	3.58e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ABCB1—kidney cancer	1.73e-06	3.57e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.73e-06	3.56e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.72e-06	3.54e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPAT—kidney cancer	1.72e-06	3.54e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTEN—kidney cancer	1.72e-06	3.54e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CTNNB1—kidney cancer	1.72e-06	3.54e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—kidney cancer	1.71e-06	3.52e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CA9—kidney cancer	1.7e-06	3.49e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MAPK3—kidney cancer	1.69e-06	3.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—POMC—kidney cancer	1.69e-06	3.47e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GSTM1—kidney cancer	1.68e-06	3.46e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.68e-06	3.46e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTEN—kidney cancer	1.67e-06	3.45e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SCARB1—kidney cancer	1.67e-06	3.43e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—BRAF—kidney cancer	1.66e-06	3.43e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GSTP1—kidney cancer	1.66e-06	3.43e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTEN—kidney cancer	1.66e-06	3.42e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—KRAS—kidney cancer	1.66e-06	3.41e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS1—kidney cancer	1.65e-06	3.4e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CYP1A1—kidney cancer	1.65e-06	3.39e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MYC—kidney cancer	1.65e-06	3.39e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RAF1—kidney cancer	1.65e-06	3.39e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RELA—kidney cancer	1.64e-06	3.37e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—POMC—kidney cancer	1.64e-06	3.37e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ERBB2—kidney cancer	1.63e-06	3.35e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PSMD7—kidney cancer	1.62e-06	3.33e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MAPK1—kidney cancer	1.61e-06	3.32e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—kidney cancer	1.61e-06	3.31e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MTOR—kidney cancer	1.61e-06	3.31e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APRT—kidney cancer	1.6e-06	3.3e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—FH—kidney cancer	1.6e-06	3.3e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CYP1A1—kidney cancer	1.59e-06	3.28e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ABCB1—kidney cancer	1.58e-06	3.24e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—POMC—kidney cancer	1.57e-06	3.23e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTEN—kidney cancer	1.54e-06	3.18e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.54e-06	3.18e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KIT—kidney cancer	1.54e-06	3.17e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—APC—kidney cancer	1.54e-06	3.17e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—BCHE—kidney cancer	1.53e-06	3.16e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CRABP1—kidney cancer	1.53e-06	3.15e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GSTM1—kidney cancer	1.53e-06	3.15e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—KRAS—kidney cancer	1.52e-06	3.13e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PIK3CA—kidney cancer	1.52e-06	3.13e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.51e-06	3.12e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CDKN1B—kidney cancer	1.51e-06	3.1e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPC3—kidney cancer	1.51e-06	3.1e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.49e-06	3.07e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2—kidney cancer	1.48e-06	3.04e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CA2—kidney cancer	1.46e-06	3.01e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.46e-06	3.01e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CYP1A1—kidney cancer	1.45e-06	2.99e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—BRAF—kidney cancer	1.45e-06	2.98e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CRABP1—kidney cancer	1.44e-06	2.97e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCND1—kidney cancer	1.44e-06	2.96e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—JUN—kidney cancer	1.43e-06	2.95e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MAPK3—kidney cancer	1.43e-06	2.95e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALAD—kidney cancer	1.43e-06	2.94e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CTNNB1—kidney cancer	1.42e-06	2.93e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ITPR2—kidney cancer	1.42e-06	2.93e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTEN—kidney cancer	1.4e-06	2.89e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PIK3CA—kidney cancer	1.4e-06	2.88e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.39e-06	2.87e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MYC—kidney cancer	1.39e-06	2.87e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RAF1—kidney cancer	1.39e-06	2.86e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTEN—kidney cancer	1.39e-06	2.86e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RELA—kidney cancer	1.38e-06	2.85e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ERBB2—kidney cancer	1.38e-06	2.83e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MAPK1—kidney cancer	1.36e-06	2.8e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.36e-06	2.8e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MTOR—kidney cancer	1.36e-06	2.79e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.35e-06	2.79e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ITPR2—kidney cancer	1.34e-06	2.76e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.31e-06	2.7e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PGK1—kidney cancer	1.31e-06	2.69e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.31e-06	2.69e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—kidney cancer	1.3e-06	2.69e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ACHE—kidney cancer	1.3e-06	2.67e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTT1—kidney cancer	1.3e-06	2.67e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—KRAS—kidney cancer	1.29e-06	2.65e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LDHB—kidney cancer	1.28e-06	2.63e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDKN1B—kidney cancer	1.27e-06	2.62e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—kidney cancer	1.25e-06	2.58e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—kidney cancer	1.25e-06	2.57e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2—kidney cancer	1.25e-06	2.57e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SCARB1—kidney cancer	1.23e-06	2.53e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—POMC—kidney cancer	1.23e-06	2.53e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ACHE—kidney cancer	1.22e-06	2.52e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTT1—kidney cancer	1.22e-06	2.52e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTP1—kidney cancer	1.22e-06	2.51e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS1—kidney cancer	1.22e-06	2.5e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCND1—kidney cancer	1.22e-06	2.5e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PIK3CA—kidney cancer	1.21e-06	2.5e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—JUN—kidney cancer	1.21e-06	2.5e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RAF1—kidney cancer	1.21e-06	2.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CTNNB1—kidney cancer	1.2e-06	2.48e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ERBB2—kidney cancer	1.2e-06	2.46e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PSMD7—kidney cancer	1.19e-06	2.46e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—POMC—kidney cancer	1.19e-06	2.45e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK3—kidney cancer	1.19e-06	2.44e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PIK3CA—kidney cancer	1.18e-06	2.43e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MTOR—kidney cancer	1.18e-06	2.43e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—kidney cancer	1.18e-06	2.43e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTEN—kidney cancer	1.17e-06	2.41e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PIK3CA—kidney cancer	1.17e-06	2.41e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—kidney cancer	1.17e-06	2.41e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SCARB1—kidney cancer	1.16e-06	2.38e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCB1—kidney cancer	1.15e-06	2.38e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MYC—kidney cancer	1.15e-06	2.37e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS1—kidney cancer	1.15e-06	2.36e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTEN—kidney cancer	1.14e-06	2.34e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—BCHE—kidney cancer	1.13e-06	2.33e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK1—kidney cancer	1.13e-06	2.32e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PSMD7—kidney cancer	1.12e-06	2.31e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTM1—kidney cancer	1.12e-06	2.31e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC5A5—kidney cancer	1.12e-06	2.3e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CA9—kidney cancer	1.11e-06	2.28e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN1B—kidney cancer	1.11e-06	2.28e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTEN—kidney cancer	1.09e-06	2.25e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PIK3CA—kidney cancer	1.09e-06	2.24e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—POMC—kidney cancer	1.08e-06	2.23e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC2A1—kidney cancer	1.08e-06	2.22e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—BCHE—kidney cancer	1.07e-06	2.19e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KRAS—kidney cancer	1.07e-06	2.19e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.06e-06	2.19e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—kidney cancer	1.06e-06	2.18e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.05e-06	2.17e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CTNNB1—kidney cancer	1.05e-06	2.16e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.03e-06	2.12e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTEN—kidney cancer	1.02e-06	2.1e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.02e-06	2.09e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK3—kidney cancer	1e-06	2.06e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PIK3CA—kidney cancer	9.89e-07	2.04e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—kidney cancer	9.8e-07	2.02e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PIK3CA—kidney cancer	9.79e-07	2.02e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MYC—kidney cancer	9.75e-07	2.01e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK1—kidney cancer	9.53e-07	1.96e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—kidney cancer	9.48e-07	1.95e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—kidney cancer	9.47e-07	1.95e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CRABP1—kidney cancer	9.44e-07	1.94e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KRAS—kidney cancer	9.01e-07	1.85e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTP1—kidney cancer	9e-07	1.85e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ITPR2—kidney cancer	8.77e-07	1.81e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAPK3—kidney cancer	8.72e-07	1.8e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—kidney cancer	8.62e-07	1.78e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTEN—kidney cancer	8.55e-07	1.76e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MYC—kidney cancer	8.48e-07	1.75e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTP1—kidney cancer	8.48e-07	1.75e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAPK1—kidney cancer	8.3e-07	1.71e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PIK3CA—kidney cancer	8.27e-07	1.7e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTM1—kidney cancer	8.27e-07	1.7e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTEN—kidney cancer	8.27e-07	1.7e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCB1—kidney cancer	8.03e-07	1.65e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CA—kidney cancer	8.03e-07	1.65e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—kidney cancer	8e-07	1.65e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTT1—kidney cancer	8e-07	1.65e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ACHE—kidney cancer	8e-07	1.65e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—POMC—kidney cancer	7.92e-07	1.63e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP1A1—kidney cancer	7.84e-07	1.61e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KRAS—kidney cancer	7.84e-07	1.61e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTM1—kidney cancer	7.79e-07	1.6e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CA—kidney cancer	7.69e-07	1.58e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SCARB1—kidney cancer	7.57e-07	1.56e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTEN—kidney cancer	7.52e-07	1.55e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS1—kidney cancer	7.5e-07	1.54e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP1A1—kidney cancer	7.39e-07	1.52e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PSMD7—kidney cancer	7.35e-07	1.51e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CA—kidney cancer	7.2e-07	1.48e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—BCHE—kidney cancer	6.97e-07	1.43e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC5A5—kidney cancer	6.88e-07	1.42e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC2A1—kidney cancer	6.65e-07	1.37e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—kidney cancer	6.32e-07	1.3e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CA—kidney cancer	6.03e-07	1.24e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—POMC—kidney cancer	5.85e-07	1.2e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CA—kidney cancer	5.83e-07	1.2e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTP1—kidney cancer	5.54e-07	1.14e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTEN—kidney cancer	5.51e-07	1.13e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—POMC—kidney cancer	5.51e-07	1.13e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CA—kidney cancer	5.31e-07	1.09e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCB1—kidney cancer	5.25e-07	1.08e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTM1—kidney cancer	5.09e-07	1.05e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.83e-07	9.94e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—kidney cancer	4.66e-07	9.6e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—kidney cancer	4.39e-07	9.04e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTEN—kidney cancer	4.07e-07	8.37e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CA—kidney cancer	3.89e-07	8.01e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTEN—kidney cancer	3.83e-07	7.89e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—POMC—kidney cancer	3.6e-07	7.41e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—kidney cancer	2.87e-07	5.91e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CA—kidney cancer	2.87e-07	5.9e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.7e-07	5.56e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTEN—kidney cancer	2.5e-07	5.16e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.77e-07	3.64e-06	CbGpPWpGaD
